Haematological improvement as a beneficial effect during deferasirox treatment in transfusion-dependent patients with myelodysplastic syndrome

被引：6
|
作者：
Molica, Matteo [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
Breccia, Massimo [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
BLOOD TRANSFUSION | 2014年 / 12卷
关键词：
D O I：
10.2450/2013.0005-13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [1] Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
    Kikuchi, Shohei
    Kobune, Masayoshi
    Iyama, Satoshi
    Sato, Tsutomu
    Murase, Kazuyuki
    Kawano, Yutaka
    Takada, Kohichi
    Ono, Kaoru
    Kaneko, Yumiko
    Miyanishi, Koji
    Sato, Yasushi
    Hayashi, Tsuyoshi
    Takimoto, Rishu
    Kato, Junji
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 643 - 648
  • [2] Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
    Gattermann, Norbert
    Finelli, Carlo
    Della Porta, Matteo
    Fenaux, Pierre
    Stadler, Michael
    Guerci-Bresler, Agnes
    Schmid, Mathias
    Taylor, Kerry
    Vassilieff, Dominique
    Habr, Dany
    Marcellari, Andrea
    Roubert, Bernard
    Rose, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (09): : 1364 - 1371
  • [3] Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome
    Nishiuchi, Takamasa
    Okutani, Yuichi
    Fujita, Toshikazu
    Yoshida, Kazuya
    Ohnishi, Hiroaki
    Haba, Reiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 333 - 335
  • [4] Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome
    Takamasa Nishiuchi
    Yuichi Okutani
    Toshikazu Fujita
    Kazuya Yoshida
    Hiroaki Ohnishi
    Reiji Haba
    International Journal of Hematology, 2010, 91 : 333 - 335
  • [5] Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study
    Sarocchi, Matteo
    Li, Junmin
    Li, Xiao
    Wu, Depei
    Figueroa, Efreen Montano
    Rodriguez, Maria Guadalupe
    Hou, Ming
    Finelli, Carlo
    Shi, Hong-Xia
    Xiao, Zhijian
    Oliva, Esther Natalie
    Kyuchukova, Liana Gercheva
    Drummond, Mark
    Symeonidis, Argiris
    Velazquez, Eric J.
    Rivoli, Giulia
    Izquierdo, Miguel
    Kolekar, Yogita
    Spallarossa, Paolo
    Angelucci, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 2049 - 2056
  • [6] Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review
    Adams, Rebecca L. C.
    Bird, Robert J.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (02) : 93 - 102
  • [7] Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome
    List, Alan F.
    Baer, Maria R.
    Steensma, David P.
    Raza, Azra
    Esposito, Jason
    Martinez-Lopez, Noelia
    Paley, Carole
    Feigert, John
    Besa, Emmanuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) : 2134 - 2139
  • [8] Effect of deferasirox on iron overload in patients with transfusion-dependent haemoglobinopathies
    Fragomeno, Concetta
    Roccabruna, Emilio
    D'Ascola, Domenico Giuseppe
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (04) : 382 - 386
  • [9] TRANSFUSION-DEPENDENT MYELODYSPLASTIC PATIENTS RECEIVING DEFERASIROX: A LONG-TERM FOLLOW UP
    Improta, S.
    Villa, M. R.
    Volpe, A.
    Cantore, N.
    Mastrullo, L.
    HAEMATOLOGICA, 2012, 97 : 141 - 141
  • [10] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
12345